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ABSTRACT  
Background: Medicine use can be used as an indicator of state of health in a population. Knowledge about 
health and medicine use among university students is scarce. Objective: The aim of this study was to 
analyse medicine use in relation to age and gender in an university student population. Methods: A survey 
on health and medicine use among students was carried out at the University of Oslo, Norway, in 2003 by 
means of a postal questionnaire. In all, 45% (789 of 1750) students participated. Students younger than 30 
years of age (n=604) were included in the study of medicine use. Results: More female (77%) than male 
(53%) students reported use of medicines during the preceding four weeks. Female students had used more 
over the counter analgesics and more psychotropic drugs than the males. One in five students reported 
daily or weekly use of allergy medicines. Conclusions: This study showed that female university students 
below 30 years of age used more medicines than their male counterparts. The gender difference was mainly 
due to a higher use of analgesics among women. The study was performed during the pollen season in 
spring, and the high proportion of allergy medicine users indicates that many university students may have 
symptoms that can influence on their academic performance during spring exams. 
 
 
 
Legal drug use is an important indicator of the state of 
health in a population: High medicine sales or high 
consumption of a medicine indicates a high prevalence 
of the disease or symptoms the medicine has an effect 
on. The Norwegian Health Survey in 1995 revealed 
that half of the population had used one or more types 
of medicines during the preceding 14 days (1). More 
females (56%) than males (43%) had used medicines, 
and medicine use increased with age for both genders. 
These gender and age differences are also found in stu-
dies in other countries (2,3). People with short educa-
tion are found to use more medicines than people with 
long education (4). 
 State of health and use of medicines have been stu-
died in adolescents (5,6) and in the general population 
in Norway (7,8). There has been little focus on health 
and legal drug use among university students in Nor-
way and in other countries. Recent studies have shown 
an increase in mental health problems among univer-
sity students (9). The rates of increased psychological 
distress are found to be significantly higher among 
university students than among the general population 
in Canada (10). Likewise, a UK study in higher educa-
tion establishment indicated that the health of students 
is poor relative to that of their peers, and it seemed that 
the students’ emotional health was more of a problem 
than their physical health (11). 
 This study aims to describe self-reported medicine 
use among Norwegian university students in relation 
to age and gender. 
MATERIAL AND METHODS 
 
In 2003, the Student Health Service at the University 
of Oslo, Norway, launched a project to study health 
and welfare among students before and after the imple-
mentation of the Quality Reform (12). The reform was 
a multiple-level reform: a new degree structure and a 
new evaluation system as an answer to the Bologna 
Declaration on international standardization of educa-
tion (13). Further, a student loan reform, which awar-
ded students with a normal progression by converting 
39% of the loan to grant, and finally it was an educa-
tion reform with a stronger focus on quality in the 
learning environment. 
 The Oslo Student Health and Welfare Study 
(OSHWS) was collaboration between the Student 
Health Service and the University of Oslo. In all, 
31882 Norwegian citizens were registered in the Stu-
dent Archive in 2003. A random sample of 1800 was 
selected to receive a 4-page structured, self-completion 
questionnaire by mail. Of these, 50 were excluded due 
to missing address. The remaining 1750 student re-
ceived the questionnaire in May 2003 and an identical 
follow-up questionnaire in April 2005. The response 
rate was 45% (789) in 2003. 
 This paper analyses the medicine use reported in 
2003. The age of the respondents ranged from 18 to 74 
years (mean 27.8, median 25.0). Almost 77% (604) 
were younger than 30 years of age, and 9% (76) were 
older than 40 years. As medicine use increases with 
196  E.O. ROSVOLD 
Figure 1.  Proportion of students aged 18-29 years using 0, 1, 2 or ≥ 3 different drug categories. Spring 2003, 
University of Oslo, Norway, n=604. 
 
 
 
age (1-3), we wanted to study use in the younger age 
groups that included the majority of the students. 
Those who were 30 years or above (n=185) were 
therefore excluded from our analyses. The remaining 
604 students were divided into two age groups: 18-24 
years and 25-29. Mean age was 24.0; median 24.0. 
Sixty-seven percent were females. 
 The questionnaire explored issues related to health, 
life-style, personality traits and study situation in addi-
tion to demographic data, and was based on a selection 
of validated questions from other surveys such as the 
Oslo Health Study in 2000-2001 (14). Reminders were 
sent approximately three weeks after the question-
naires were first sent out. 
 Medicine use was recorded using a question from 
the Oslo Youth Health Study (14) with the following 
questions and response categories: “How often during 
the last four weeks have you taken a) over the counter 
(OCT) analgesics b) prescription analgesics c) allergy 
medicines d) asthma medicines e) hypnotics f) anxio-
lytics g) antidepressants h) other prescription medi-
cines?” The answering categories were given as 1) 
Never; 2) Daily; 3) Every week, but not daily; 4) Less 
often than every week; 5) Not taken during the last 
four weeks. Persons who answered 2, 3 or 4 were de-
fined as medicine users. 
 Bivariate analyses (Fisher’s Exact Test) were per-
formed by use of SPSS version 14. The significance 
level was set to p≤0.05. The Oslo Student Health and 
Welfare Study was reported to the Privacy Issues Unit, 
Norwegian Social Science Data Services. It was also 
approved by the National Committee for Research 
Ethics in Norway. 
 
 
RESULTS 
 
In all, 53% of the male and 77% of the female students 
had used medicines during the last four weeks before 
they answered the questionnaire (Figure 1). Most of 
the students had only used one type of medication, but 
6% men and 12% women reported use of three or 
more drugs. 
 None of the students used analgesics daily, but 35% 
males and 67% females had used OTC analgesics 
during the last four weeks, while 4% males and 5% 
females had used prescription analgesics (Table 1). 
Among men the amount of OTC users and users of the 
group ”other medicines” were higher in the oldest age 
group as compared to the youngest (p=0.001 and 
p=0.03, respectively). No other differences in drug use 
were found between the two age groups (Figure 2). 
 Although there were some gender differences in 
frequency of use of allergy medicines, male and fe-
male students had rather similar proportion of users of 
these drugs (28-24%). One in five students used aller-
gy medicines daily or weekly. There were no gender 
differences in use of asthma medicines. Six percent of 
the students had used asthma medicines during the last 
month, and 3.5% used asthma medicines daily. 
 Altogether 2% males and 6% females (p=0.018) 
were using one or more of the three psychotropics 
listed; antidepressants being the largest group. More 
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Figure 2.  Proportion of students aged 18-29 years using different types of medicines during four weeks in spring  
2003, University of Oslo, Norway, n=604. 
 
 
 
Table 1.  Number (%) of students at the University of Oslo, Norway, (n= 604), using different groups of medicines during a four 
week period in spring 2003. 
 
  Frequency of use  
OTC 
analgesics 
Prescription 
analgesics 
Allergy 
medicine 
Asthma 
medicine Hypnotics Anxiolytics 
Anti-
depressants 
Other 
prescription 
medicines 
Males Daily  0** 0     25 (12.9)*  8 (4.1) 0 0   1 (0.5)      9 (4.6)** 
N=198 Weekly, but not daily  7 (3.6) 0   9 (4.6)  1 (0.5) 0 0   1 (0.5)  1 (0.5) 
 Less than weekly   61 (31.0)  7 (3.6)   20 (10.3)  4 (2.0)   1 (0.5) 0 0  8 (4.1) 
 
No use during the last 
four weeks/ Never  129 (65.5) 189 (96.4) 140 (72.2) 183 (93.4) 195 (99.5) 196 (100) 194 (99.0) 177 (90.8) 
Females Daily 0 0   52 (13.1) 13 (3.2)   1 (0.3)    1 (0.3) 10 (2.5)   62 (15.5) 
N=406 Weekly, but not daily   54 (13.5)   3 (0.8) 29 (7.3)    5 (1.2)   3 (0.8)    1 (0.3) 0 10 (2.5) 
 Less than weekly  213 (53.1) 17 (4.3) 15 (3.8)    5 (1.2)   8 (2.0)    6 (1.5)   1 (0.3) 19 (4.8)  
 
No use during the last 
four weeks/ Never  134 (33.4) 378 (95.0) 302 (75.9)  378 (94.3)  387 (97.0) 391 (98.0) 388 (97.2) 308 (77.2) 
Differences between males and females (Fisher’s Exact Test)  * p<0.05  **p<0.001 
 
 
 
females than males reported use of other prescription 
medicines. 
 
 
DISCUSSION 
 
More female than male university students had used 
one ore more medicines during the last four weeks. 
This is in concordance with findings in the general 
population in Norway and other countries (1-3). The 
largest gender difference was found in use of OTC 
analgesics in the age group 18-24 years (69% women 
versus 25% men, Figure 2). Such gender difference is 
also found among Norwegian adolescents aged 15-16 
years (5). However, whilst the male university students 
had almost the same proportion of OTC analgesics 
users as the male adolescents (23%), the female stu-
dents reported higher use than the younger girls (69% 
versus 54%). The proportion among male students rose 
to 43% in the age group 25-29 years, whereas the 
female proportion remained stable. This indicates that 
females reach adult level of analgesics use at an earlier 
age than males do. 
 None of the university students reported daily use 
of OTC analgesic. This is in contrast to studies of 
Norwegian adolescents (1% daily users) (5) and adults 
aged 20-49 years (1-2% daily users) (15). A reason for 
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this may be that university students are a selected 
group of people with rather good health, i.e. people 
with chronic pain symptoms may not be a part of this 
group. 
 Almost 13 percent of the students used allergy me-
dicines daily. One in five reported daily or weekly use 
of such drugs. During 2004 13.7% of the general po-
pulation aged 20-29 was prescribed allergy medicines 
(16). The high prevalence of daily or weekly use of 
allergy medicine is probably due to the fact that data 
were collected in the pollen season in spring. How-
ever, spring is also the examination period, and the 
results shows that many university students suffer 
from allergy symptoms that might influence their exa-
mination results in a negative direction. 
 More women than men used psychotropic drugs. 
The female university students in our survey also re-
ported more mental distress than the males did (17). 
The same gender difference in mental distress is found 
in the general population (18). Few students reported 
use of antidepressants (1% of males and 2.8% of fe-
males). According to the Norwegian Prescription Data 
Base 3.2% men and 4.9% women in the general popu-
lation aged 20-29 years were prescribed antidepres-
sants in 2004 (16). The smaller figures among uni-
versity students might be a result of the selection of 
healthy people into higher education, but it may also 
be that students with health problems have been less 
likely to answer the questionnaires. 
 The female students were more likely than the 
males to report use of other prescription medicines. 
These figures probably include contraceptive pills. 
However, data from the Norwegian Prescription Data-
base show that 28% of all women aged 15-49 years 
received contraceptive pills in 2006 (19), and the pro-
portion of users are highest in the age group 20-29 
(20). As the group “other prescription medicines” also 
will include other medicines than oral contraceptives, 
there is probably an underreporting of p-pills in our 
survey. The low frequency of reporting might reflect 
that many women do not regard oral contraceptives as 
medicine as they do not use them to cure a disease. 
 The low response rate dictates the need for caution 
in interpretation of the results. One reason for non-
response might be that the survey was conducted du-
ring the examination period. Students who experience 
high stress during this period might be less likely than 
others to spend time to participate in a survey. As 
stress and anxiety is a reason for use of psychotropic 
medications, this may have led to an underestimation 
of such medicines in our study. 
 Thirty percent (530) of the students in the survey 
population were not registered as students the follow-
ing term, indicating that they had finished or termi-
nated their studies at the University of Oslo (21). Of 
these, only 32% filled in the questionnaire, as com-
pared to 49% among those who were still registered 
(unpublished data). A study of drop outs from Norwe-
gian universities revealed that 46% of all students left 
their original study place to start on a new study; and 
another 10% stopped studying (22). Although some 
students may drop out because of health problems, it is 
probable that the low response rate among the students 
who were about to drop out of the curriculum at the 
University of Oslo, was due to reasons that did not 
influence their use of medication. 
 A comparison of age and gender of the respondents 
with that of the total student population at the Uni-
versity of Oslo in 2003 revealed that the response 
group comprised of slightly more women (65% in the 
response group as compared to 60% in the student 
population) (17). As women use more medicines than 
men, the higher amount of women in the response 
group might lead to an overestimation of medicine use 
in this study. 
 
 
CONCLUSION 
 
The university students below the age of 30 in this 
study show the same gender difference in medicine use 
as the general population, with women reporting more 
use than men. The study was performed during the 
pollen season, and revealed that one in five students 
used allergy medicine daily or weekly. This indicates 
that many university students may have symptoms that 
can influence on their academic performance. 
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